Clinical Trial Update: Amifostine With IMRT for Submandibular and Sublingual Salivary Sparing During Head and Neck Cancer Treatment [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating amifostine with intensity-modulated radiotherapy for sparing submandibular and sublingual salivary glands during head and neck cancer t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Amifostine (amifostine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Head and Neck Cancer | Phase 2 | Status: TERMINATED | Results posted: 2010-01-18